The KCNK1 Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population generated via target-gene disruption of the KCNK1 locus in Homo sapiens HT29 colorectal adenocarcinoma cells. This polyclonal product provides a heterogeneous loss-of-function model for studying the physiological and pathological roles of the TWIK-1 potassium channel. The CRISPR/Cas9-mediated gene disruption allows researchers to investigate KCNK1-dependent cellular processes without relying on pharmacological inhibitors, thereby enhancing specificity in functional assays.
HT29 is a well-characterized human colorectal adenocarcinoma cell line originally derived from the primary tumor of a 44-year-old female patient. These epithelial cells exhibit a differentiated phenotype and can be induced to form enterocyte-like structures, making them a versatile platform for investigating colon cancer biology, drug transport mechanisms, and intestinal differentiation. The adherent HT29 line retains key oncogenic mutations and signaling networks relevant to colorectal carcinogenesis, providing a robust background in which to assess the impact of KCNK1 ablation.
KCNK1, also known as TWIK-1, belongs to the two-pore domain potassium channel family and functions as a background leak channel that stabilizes the resting membrane potential. In HT29 cells, KCNK1-mediated potassium efflux regulates cell excitability, volume homeostasis, and proliferation by modulating downstream targets such as membrane potential, calcium signaling, and MAPK/ERK pathway activity. The channel is activated by GPCR signaling, phospholipase C, PKA, PKC, pH, and mechanical stretch, and interacts with 14-3-3 proteins, ARF6, G?¦? subunits, KCNK2 (TREK-1), and KCNK3 (TASK-1). Its functional output influences cell cycle progression and apoptosis, in part through caspase activation and MAPK/ERK signaling, establishing a mechanistic link between potassium ion transport and tumor cell behavior.
Within the HT29 colorectal adenocarcinoma model, disruption of KCNK1 is predicted to perturb ion homeostasis and alter the resting membrane potential, thereby compromising the regulatory cascades that control proliferation and survival. This polyclonal knockout cell population enables the dissection of KCNK1??s contributions to colon cancer progression, from its impact on cell volume regulation and membrane potential dynamics to its integration with oncogenic pathways such as MAPK/ERK. Given the role of potassium channels in apoptosis resistance and cell cycle regulation, this model is particularly suited for exploring how loss of TWIK-1 influences tumorigenic potential and responsiveness to chemotherapeutic agents.
Researchers can employ these polyclonal knockout cells in a broad range of experimental approaches, including western blotting and RT-qPCR for expression profiling, patch-clamp electrophysiology for channel activity, MTT and Annexin V assays for proliferation and apoptosis, transwell migration/invasion tests, and RNA-seq transcriptomics to capture global gene expression changes. Applications extend to investigating KCNK1 function in colon cancer, validating ion channels as drug targets, studying membrane potential-dependent signaling, and assessing epithelial cell volume regulation. For further information and technical support, please contact Ascent Research.
